Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 107
Filtrar
1.
Med Phys ; 42(12): 7098-107, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26632063

RESUMEN

PURPOSE: This paper presents initial experimental results from a prototype of high dose rate (HDR) BrachyView, a novel in-body source tracking system for HDR brachytherapy based on a multipinhole tungsten collimator and a high resolution pixellated silicon detector array. The probe and its associated position estimation algorithms are validated and a comprehensive evaluation of the accuracy of its position estimation capabilities is presented. METHODS: The HDR brachytherapy source is moved through a sequence of positions in a prostate phantom, for various displacements in x, y, and z. For each position, multiple image acquisitions are performed, and source positions are reconstructed. Error estimates in each dimension are calculated at each source position and combined to calculate overall positioning errors. Gafchromic film is used to validate the accuracy of source placement within the phantom. RESULTS: More than 90% of evaluated source positions were estimated with an error of less than one millimeter, with the worst-case error being 1.3 mm. Experimental results were in close agreement with previously published Monte Carlo simulation results. CONCLUSIONS: The prototype of HDR BrachyView demonstrates a satisfactory level of accuracy in its source position estimation, and additional improvements are achievable with further refinement of HDR BrachyView's image processing algorithms.


Asunto(s)
Braquiterapia/instrumentación , Braquiterapia/métodos , Próstata/diagnóstico por imagen , Radioterapia Guiada por Imagen/instrumentación , Radioterapia Guiada por Imagen/métodos , Algoritmos , Diagnóstico por Imagen/instrumentación , Diagnóstico por Imagen/métodos , Diseño de Equipo , Humanos , Masculino , Modelos Biológicos , Fantasmas de Imagen , Próstata/efectos de la radiación , Radiografía , Radiometría/instrumentación , Radiometría/métodos , Dosificación Radioterapéutica , Silicio , Tungsteno
2.
Phys Med Biol ; 59(21): 6659, 2014 Nov 07.
Artículo en Inglés | MEDLINE | ID: mdl-25325249

RESUMEN

HDR BrachyView is a novel in-body dosimetric imaging system for real-time monitoring and verification of the source position in high dose rate (HDR) prostate brachytherapy treatment. It is based on a high-resolution pixelated detector array with a semi-cylindrical multi-pinhole tungsten collimator and is designed to fit inside a compact rectal probe, and is able to resolve the 3D position of the source with a maximum error of 1.5 mm. This paper presents an evaluation of the additional dose that will be delivered to the patient as a result of backscatter radiation from the collimator. Monte Carlo simulations of planar and cylindrical collimators embedded in a tissue-equivalent phantom were performed using Geant4, with an (192)Ir source placed at two different source-collimator distances. The planar configuration was replicated experimentally to validate the simulations, with a MOSkin dosimetry probe used to measure dose at three distances from the collimator. For the cylindrical collimator simulation, backscatter dose enhancement was calculated as a function of axial and azimuthal displacement, and dose distribution maps were generated at three distances from the collimator surface. Although significant backscatter dose enhancement was observed for both geometries immediately adjacent to the collimator, simulations and experiments indicate that backscatter dose is negligible at distances beyond 1 mm from the collimator. Since HDR BrachyView is enclosed within a 1 mm thick tissue-equivalent plastic shell, all backscatter radiation resulting from its use will therefore be absorbed before reaching the rectal wall or other tissues. dosimetry, brachytherapy, HDR.


Asunto(s)
Braquiterapia/instrumentación , Braquiterapia/métodos , Fantasmas de Imagen , Neoplasias de la Próstata/radioterapia , Dosificación Radioterapéutica , Radioterapia Guiada por Imagen/métodos , Tungsteno/química , Simulación por Computador , Humanos , Procesamiento de Imagen Asistido por Computador/métodos , Masculino , Método de Montecarlo , Neoplasias de la Próstata/patología , Dispersión de Radiación , Programas Informáticos
3.
Med Phys ; 40(7): 071715, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23822419

RESUMEN

PURPOSE: High dose rate (HDR) brachytherapy is a form of radiation therapy for treating prostate cancer whereby a high activity radiation source is moved between predefined positions inside applicators inserted within the treatment volume. Accurate positioning of the source is essential in delivering the desired dose to the target area while avoiding radiation injury to the surrounding tissue. In this paper, HDR BrachyView, a novel inbody dosimetric imaging system for real time monitoring and verification of the radioactive seed position in HDR prostate brachytherapy treatment is introduced. The current prototype consists of a 15 × 60 mm(2) silicon pixel detector with a multipinhole tungsten collimator placed 6.5 mm above the detector. Seven identical pinholes allow full imaging coverage of the entire treatment volume. The combined pinhole and pixel sensor arrangement is geometrically designed to be able to resolve the three-dimensional location of the source. The probe may be rotated to keep the whole prostate within the transverse plane. The purpose of this paper is to demonstrate the efficacy of the design through computer simulation, and to estimate the accuracy in resolving the source position (in detector plane and in 3D space) as part of the feasibility study for the BrachyView project. METHODS: Monte Carlo simulations were performed using the GEANT4 radiation transport model, with a (192)Ir source placed in different locations within a prostate phantom. A geometrically accurate model of the detector and collimator were constructed. Simulations were conducted with a single pinhole to evaluate the pinhole design and the signal to background ratio obtained. Second, a pair of adjacent pinholes were simulated to evaluate the error in calculated source location. RESULTS: Simulation results show that accurate determination of the true source position is easily obtainable within the typical one second source dwell time. The maximum error in the estimated projection position was found to be 0.95 mm in the imaging (detector) plane, resulting in a maximum source positioning estimation error of 1.48 mm. CONCLUSIONS: HDR BrachyView is a feasible design for real-time source tracking in HDR prostate brachytherapy. It is capable of resolving the source position within a subsecond dwell time. In combination with anatomical information obtained from transrectal ultrasound imaging, HDR BrachyView adds a significant quality assurance capability to HDR brachytherapy treatment systems.


Asunto(s)
Braquiterapia/métodos , Imagen Molecular/métodos , Método de Montecarlo , Neoplasias de la Próstata/radioterapia , Radioterapia Guiada por Imagen/métodos , Estudios de Factibilidad , Humanos , Procesamiento de Imagen Asistido por Computador , Masculino , Radiometría
4.
Med Phys ; 40(4): 041709, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23556879

RESUMEN

PURPOSE: The conformity of the achieved dose distribution to the treatment plan strongly correlates with the accuracy of seed implantation in a prostate brachytherapy treatment procedure. Incorrect seed placement leads to both short and long term complications, including urethral and rectal toxicity. The authors present BrachyView, a novel concept of a fast intraoperative treatment planning system, to provide real-time seed placement information based on in-body gamma camera data. BrachyView combines the high spatial resolution of a pixellated silicon detector (Medipix2) with the volumetric information acquired by a transrectal ultrasound (TRUS). The two systems will be embedded in the same probe so as to provide anatomically correct seed positions for intraoperative planning and postimplant dosimetry. Dosimetric calculations are based on the TG-43 method using the real position of the seeds. The purpose of this paper is to demonstrate the feasibility of BrachyView using the Medipix2 pixel detector and a pinhole collimator to reconstruct the real-time 3D position of low dose-rate brachytherapy seeds in a phantom. METHODS: BrachyView incorporates three Medipix2 detectors coupled to a multipinhole collimator. Three-dimensionally triangulated seed positions from multiple planar images are used to determine the seed placement in a PMMA prostate phantom in real time. MATLAB codes were used to test the reconstruction method and to optimize the device geometry. RESULTS: The results presented in this paper show a 3D position reconstruction accuracy of the seed in the range of 0.5-3 mm for a 10-60 mm seed-to-detector distance interval (Z direction), respectively. The BrachyView system also demonstrates a spatial resolution of 0.25 mm in the XY plane for sources at 10 mm distance from Medipix2 detector plane, comparable to the theoretical value calculated for an equivalent gamma camera arrangement. The authors successfully demonstrated the capability of BrachyView for real-time imaging (using a 3 s data acquisition time) of different brachytherapy seed configurations (with an activity of 0.05 U) throughout a 60 × 60 × 60 mm(3) Perspex prostate phantom. CONCLUSIONS: The newly developed miniature gamma camera component of BrachyView, with its high spatial resolution and real time capability, allows accurate 3D localization of seeds in a prostate phantom. Combination of the gamma camera with TRUS in a single probe will complete the BrachyView system.


Asunto(s)
Braquiterapia/métodos , Cámaras gamma , Neoplasias de la Próstata/diagnóstico por imagen , Neoplasias de la Próstata/radioterapia , Cintigrafía/instrumentación , Radioterapia Guiada por Imagen/instrumentación , Diseño de Equipo , Análisis de Falla de Equipo , Humanos , Masculino , Fantasmas de Imagen , Proyectos Piloto , Cintigrafía/métodos , Dosificación Radioterapéutica , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Resultado del Tratamiento
5.
Radiat Prot Dosimetry ; 143(2-4): 398-401, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21199825

RESUMEN

Radiation in space generally produces higher dose rates than that on the Earth's surface, and contributions from primary galactic and solar events increase with altitude within the magnetosphere. Presently, no personnel monitor is available to astronauts for real-time monitoring of dose, radiation quality and regulatory risk. This group is developing a prototypic instrument for use in an unknown, time-varying radiation field. This microdosemeter-dosemeter nucleon instrument is for use in a spacesuit, spacecraft, remote rover and other applications. It provides absorbed dose, dose rate and dose equivalent in real time so that action can be taken to reduce exposure. Such a system has applications in health physics, anti-terrorism and radiation-hardening of electronics as well. The space system is described and results of ground-based studies are presented and compared with predictions of transport codes. An early prototype in 2007 was successfully launched, the only solid-state microdosemeter to have flown in space.


Asunto(s)
Materiales Biomiméticos , Carga Corporal (Radioterapia) , Radiación Cósmica , Monitoreo de Radiación/instrumentación , Nave Espacial/instrumentación , Recuento Corporal Total/instrumentación , Diseño de Equipo , Análisis de Falla de Equipo , Humanos , Miniaturización , Dosis de Radiación , Efectividad Biológica Relativa , Medición de Riesgo/métodos
6.
Phys Med Biol ; 55(16): 4687-702, 2010 Aug 21.
Artículo en Inglés | MEDLINE | ID: mdl-20671352

RESUMEN

A model of irradiated cell survival based on rigorous accounting of microdosimetric effects is developed. The model does not assume that the distribution of lesions is Poisson and is applicable to low, intermediate and high acute doses of low or high LET radiation. For small doses, the model produces the linear-quadratic (LQ) model. However, for high doses the best-fitting LQ model grossly underestimates cell survival. The same is also true for the conventional LQ model, only more so. It is shown that for high doses, the microdosimetric distribution can be approximated by a Gaussian distribution, and the corresponding cell survival probabilities are compared.


Asunto(s)
Radiometría/métodos , Algoritmos , Supervivencia Celular , Humanos , Modelos Lineales , Modelos Biológicos , Modelos Estadísticos , Distribución Normal , Distribución de Poisson , Probabilidad , Tolerancia a Radiación , Radiación Ionizante , Reproducibilidad de los Resultados
7.
Radiat Prot Dosimetry ; 120(1-4): 421-6, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16785245

RESUMEN

MIDN (MIcroDosimetry iNstrument) is a payload on the MidSTAR-I spacecraft (Midshipman Space Technology Applications Research) under development at the United States Naval Academy. MIDN is a solid-state system being designed and constructed to measure microdosimetric spectra to determine radiation quality factors for space environments. Radiation is a critical threat to the health of astronauts and to the success of missions in low-Earth orbit and space exploration. The system will consist of three separate sensors, one external to the spacecraft, one internal and one embedded in polyethylene. Design goals are mass <3 kg and power <2 W. The MidSTAR-I mission in 2006 will provide an opportunity to evaluate a preliminary version of this system. Its low power and mass makes it useful for the International Space Station and manned and unmanned interplanetary missions as a real-time system to assess and alert astronauts to enhanced radiation environments.


Asunto(s)
Radiación Cósmica , Exposición Profesional/análisis , Protección Radiológica/instrumentación , Procesamiento de Señales Asistido por Computador/instrumentación , Vuelo Espacial/instrumentación , Dosimetría Termoluminiscente/instrumentación , Relación Dosis-Respuesta en la Radiación , Diseño de Equipo , Análisis de Falla de Equipo , Miniaturización , Dosis de Radiación , Reproducibilidad de los Resultados , Investigación , Sensibilidad y Especificidad , Vuelo Espacial/métodos , Propiedades de Superficie , Dosimetría Termoluminiscente/métodos , Interfaz Usuario-Computador
8.
Radiat Prot Dosimetry ; 120(1-4): 48-55, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16644949

RESUMEN

Silicon mini-semiconductor detectors are found in wide applications for in vivo personal dosimetry and dosimetry and microdosimetry of different radiation oncology modalities. These applications are based on integral and spectroscopy modes of metal oxide semiconductor field effect transistor and silicon p-n junction detectors. The advantages and limitations of each are discussed.


Asunto(s)
Semiconductores , Dosimetría Termoluminiscente/instrumentación , Dosimetría Termoluminiscente/métodos , Diseño de Equipo , Miniaturización , Evaluación de la Tecnología Biomédica , Transductores
9.
Phys Med Biol ; 50(13): 3063-81, 2005 Jul 07.
Artículo en Inglés | MEDLINE | ID: mdl-15972981

RESUMEN

The need for fast, accurate and high resolution dosimetric quality assurance in radiation therapy has been outpacing the development of new and improved 2D and 3D dosimetry techniques. This paper summarizes the efforts to create a novel and potentially very fast, 3D dosimetry method based on the observation of scintillation light from an irradiated liquid scintillator volume serving simultaneously as a phantom material and as a dose detector medium. The method, named three-dimensional scintillation dosimetry (3DSD), uses visible light images of the liquid scintillator volume at multiple angles and applies a tomographic algorithm to a series of these images to reconstruct the scintillation light emission density in each voxel of the volume. It is based on the hypothesis that with careful design and data processing, one can achieve acceptable proportionality between the local light emission density and the locally absorbed dose. The method is applied to a Ru-106 eye plaque immersed in a 16.4 cm3 liquid scintillator volume and the reconstructed 3D dose map is compared along selected profiles and planes with radiochromic film and diode measurements. The comparison indicates that the 3DSD method agrees, within 25% for most points or within approximately 2 mm distance to agreement, with the relative radiochromic film and diode dose distributions in a small (approximately 4.5 mm high and approximately 12 mm diameter) volume in the unobstructed, high gradient dose region outside the edge of the plaque. For a comparison, the reproducibility of the radiochromic film results for our measurements ranges from 10 to 15% within this volume. At present, the 3DSD method is not accurate close to the edge of the plaque, and further than approximately 10 mm (<10% central axis depth dose) from the plaque surface. Improvement strategies, considered important to provide a more accurate quick check of the dose profiles in 3D for brachytherapy applicators, are discussed.


Asunto(s)
Braquiterapia/instrumentación , Braquiterapia/métodos , Imagenología Tridimensional/métodos , Radioisótopos de Rutenio/administración & dosificación , Radioisótopos de Rutenio/uso terapéutico , Conteo por Cintilación/métodos , Relación Dosis-Respuesta en la Radiación , Análisis de Falla de Equipo/métodos , Neoplasias del Ojo/patología , Neoplasias del Ojo/radioterapia , Humanos , Imagenología Tridimensional/instrumentación , Dosis de Radiación , Reproducibilidad de los Resultados , Conteo por Cintilación/instrumentación , Sensibilidad y Especificidad
10.
Phys Med Biol ; 48(9): 1153-71, 2003 May 07.
Artículo en Inglés | MEDLINE | ID: mdl-12765329

RESUMEN

This paper describes analytic tools in support of a paradigm shift in brachytherapy treatment planning for prostate cancer--a shift from standard pre-planning to intraoperative planning using dosimetric feedback based on the actual deposited seed positions within the prostate. The method proposed is guided by several desiderata: (a) bringing both planning and evaluation in the operating room (i.e. make post-implant evaluation superfluous) therefore making rectifications--if necessary--still achievable; (b) making planning and implant evaluation consistent by using the same imaging system (ultrasound); and (c) using only equipment commonly found in a hospital operating room. The intraoperative dosimetric evaluation is based on the fusion between ultrasound images and 3D seed coordinates reconstructed from fluoroscopic projections. Automatic seed detection and registration of the fluoroscopic and ultrasound information, two of the three key ingredients needed for the intraoperative dynamic dosimetry optimization (IDDO), are explained in detail. The third one, the reconstruction of 3D coordinates from projections, was reported in a previous article. The algorithms were validated using a custom-designed phantom with non-radioactive (dummy) seeds. Also, fluoroscopic images were taken at the conclusion of an actual permanent prostate implant and compared with data on the same patient obtained from radiographic-based post-implant evaluation. To offset the effect of organ motion the comparison was performed in terms of the proximity function of the two seed distributions. The agreement between the intra- and post-operative seed distributions was excellent.


Asunto(s)
Algoritmos , Braquiterapia/métodos , Fluoroscopía/métodos , Neoplasias de la Próstata/radioterapia , Radiometría/métodos , Planificación de la Radioterapia Asistida por Computador/métodos , Radioterapia Asistida por Computador/métodos , Humanos , Aumento de la Imagen/métodos , Masculino , Monitoreo Intraoperatorio/métodos , Neoplasias de la Próstata/diagnóstico por imagen , Dosificación Radioterapéutica , Técnica de Sustracción , Ultrasonografía
11.
Radiat Prot Dosimetry ; 101(1-4): 431-4, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12382784

RESUMEN

A report of recent developments in silicon microdosimetry is presented. SOI based microdosemeters have shown promise as a viable alternative to traditional tissue-equivalent proportional counters. The application of these silicon microdosemeters to such radiation therapy modalities as boron neutron capture therapy (BNCT), boron neutron capture synovectomy (BNCS), proton therapy (PT), and fast neutron therapy (FNT) has been performed. Several shortcomings of the current silicon microdosemeter were identified and will be taken into account in the design of a second-generation device.


Asunto(s)
Terapia por Captura de Neutrón de Boro/métodos , Neutrones Rápidos , Protones , Terapia por Captura de Neutrón de Boro/instrumentación , Humanos , Dosificación Radioterapéutica
12.
Phys Med Biol ; 47(16): N209-15, 2002 Aug 21.
Artículo en Inglés | MEDLINE | ID: mdl-12222865

RESUMEN

One limitation of intraoperative planning of permanent prostate implants is that needles must already be in the gland before planning images are acquired. Improperly placed needles often restrict the capability of generating optimal seed placement. We developed guiding principles for the proper layout of needles within the treatment volume. The Memorial Sloan-Kettering Cancer Center planning system employs a genetic algorithm to find the optimal seed implantation pattern consistent with pre-assigned constraints (needle geometry, uniformity, conformity and the avoidance of high doses to urethra and rectum). Ultrasound volumes for twelve patients with 1-125 implants were used to generate six plans per patient (total 72 plans) with different needle arrangements. The plans were evaluated in terms of V100 (percentage prostate volume receiving at least the prescription dose), U135 (percentage urethra volume receiving at least 135% of prescription dose), and CI (conformity index, the ratio of treatment volume to prescription dose volume.) The method termed POSTCTR, in which needles were placed on the periphery of the largest ultrasound slice and posterior central needles were placed as needed, consistently gave superior results for all prostate sizes. Another arrangement, labelled POSTLAT, where the needles were placed peripherally with additional needles in the posterior lateral lobes, also gave satisfactory results. We advocate two needle arrangements, POSTCTR and POSTLAT, with the former giving better results.


Asunto(s)
Algoritmos , Braquiterapia/métodos , Radioisótopos de Yodo/administración & dosificación , Neoplasias de la Próstata/radioterapia , Planificación de la Radioterapia Asistida por Computador/métodos , Estudios de Cohortes , Simulación por Computador , Humanos , Masculino , Agujas , Control de Calidad , Dosificación Radioterapéutica , Estudios Retrospectivos , Sensibilidad y Especificidad
13.
Phys Med Biol ; 47(12): 2031-48, 2002 Jun 21.
Artículo en Inglés | MEDLINE | ID: mdl-12118599

RESUMEN

In brachytherapy implants, the accuracy of dose calculation depends on the ability to localize radioactive sources correctly. If performed manually using planar images, this is a time-consuming and often error-prone process-primarily because each seed must be identified on (at least) two films. In principle, three films should allow automatic seed identification and position reconstruction; however, practical implementation of the numerous algorithms proposed so far appears to have only limited reliability. The motivation behind this work is to create a fast and reliable system for real-time implant evaluation using digital planar images obtained from radiotherapy simulators, or mobile x-ray/fluoroscopy systems. We have developed algorithms and code for 3D seed coordinate reconstruction. The input consists of projections of seed positions in each of three isocentric images taken at arbitrary angles. The method proposed here consists of a set of heuristic rules (in a sense, a learning algorithm) that attempts to minimize seed misclassifications. In the clinic, this means that the system must be impervious to errors resulting from patient motion as well as from finite tolerances accepted in equipment settings. The software program was tested with simulated data, a pelvic phantom and patient data. One hundred and twenty permanent prostate implants were examined (105 125I and 15 103Pd) with the number of seeds ranging from 35 to 138 (average 79). The mean distance between actual and reconstructed seed positions is in the range 0.03-0.11 cm. On a Pentium III computer at 600 MHz the reconstruction process takes 10-30 s. The total number of seeds is independently validated. The process is robust and able to account for errors introduced in the clinic.


Asunto(s)
Braquiterapia/instrumentación , Braquiterapia/métodos , Algoritmos , Humanos , Masculino , Modelos Estadísticos , Fantasmas de Imagen , Neoplasias de la Próstata/radioterapia , Radiometría/métodos , Planificación de la Radioterapia Asistida por Computador
14.
Phys Med Biol ; 46(10): 2745-58, 2001 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11686286

RESUMEN

This paper explores the applicability of a mechanistic survival model, based on the distribution of clonogens surviving a course of fractionated radiation therapy, to clinical data on patients with prostate cancer. The study was carried out using data on 1,100 patients with clinically localized prostate cancer who were treated with three-dimensional conformal radiation therapy. The patients were stratified by radiation dose (group 1: <67.5 Gy; group 2: 67.5-72.5 Gy; group 3: 72.5-77.5 Gy; group 4: 77.5-87.5 Gy) and prognosis category (favourable, intermediate and unfavourable as defined by pre-treatment PSA and Gleason score). A relapse was recorded when tumour recurrence was diagnosed or when three successive prostate specific antigen (PSA) elevations were observed from a post-treatment nadir PSA level. PSA relapse-free survival was used as the primary end point. The model, which is based on an iterated Yule process, is specified in terms of three parameters: the mean number of tumour clonogens that survive the treatment, the mean of the progression time of post-treatment tumour development and its standard deviation. The model parameters were estimated by the maximum likelihood method. The fact that the proposed model provides an excellent description both of the survivor function and of the hazard rate is prima facie evidence of the validity of the model because closeness of the two survivor functions (empirical and model-based) does not generally imply closeness of the corresponding hazard rates. The estimated cure probabilities for the favourable group are 0.80, 0.74 and 0.87 (for dose groups 1-3, respectively); for the intermediate group: 0.25, 0.51, 0.58 and 0.78 (for dose groups 1-4, respectively) and for the unfavourable group: 0.0, 0.27, 0.33 and 0.64 (for dose groups 1-4, respectively). The distribution of progression time to tumour relapse was found to be independent of prognosis group but dependent on dose. As the dose increases the mean progression time decreases (41, 28.5, 26.2 and 14.7 months for dose groups 1-4, respectively). This analysis confirms that, in terms of cure rate, dose escalation has a significant positive effect only in the intermediate and unfavourable groups. It was found that progression time is inversely proportional to dose, which means that patients recurring in higher dose groups have shorter recurrence times, yet these groups have better survival, particularly long-term. The explanation for this seemingly illogical observation lies in the fact that less aggressive tumours, potentially recurring after a long period of time, are cured by higher doses and do not contribute to the recurrence pattern. As a result, patients in higher dose groups are less likely to recur; however, if they do, they tend to recur earlier. The estimated hazard rates for prostate cancer pass through a clear-cut maximum, thus revealing a time period with especially high values of instantaneous cancer-specific risk; the estimates appear to be nonproportional across dose strata.


Asunto(s)
Fraccionamiento de la Dosis de Radiación , Neoplasias de la Próstata/radioterapia , Radioterapia/métodos , Supervivencia sin Enfermedad , Relación Dosis-Respuesta en la Radiación , Humanos , Masculino , Modelos Estadísticos , Pronóstico , Neoplasias de la Próstata/diagnóstico , Neoplasias de la Próstata/mortalidad , Recurrencia , Factores de Tiempo , Resultado del Tratamiento
15.
J Appl Clin Med Phys ; 2(2): 85-9, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11604053

RESUMEN

The BANG (MGS Research Inc., Guilford, CT) polymer gel has been used as a dosimeter to determine the three-dimensional (3D) dose distribution of a ruthenium-106 (Ru-106) ophthalmologic applicator. An eye phantom made of the BANG gel was irradiated with the Ru-106 source for up to 1 h. The phantom and a set of calibration vials were scanned simultaneously in a GE 1.5 T MR imager using the Hahn spin-echo pulse sequence with a TR of 2000 ms and two TEs of 20 ms and 100 ms. The T(2) values were evaluated on a pixel-by-pixel basis using custom-built software on a DEC alpha workstation and converted to dose using calibration data. Depth doses and isodose lines of the Ru-106 eye-plaque were generated. It is concluded that the BANG gel dosimetry offers the potential for measuring the 3D dose distributions of an ophthalmologic applicator, with high spatial resolution and relatively good accuracy.


Asunto(s)
Braquiterapia/métodos , Neoplasias del Ojo/radioterapia , Geles , Melanoma/radioterapia , Fantasmas de Imagen , Polímeros , Monitoreo de Radiación/instrumentación , Radioisótopos de Rutenio , Humanos , Imagenología Tridimensional/métodos , Imagen por Resonancia Magnética/métodos , Neoplasias de la Retina/radioterapia , Retinoblastoma/radioterapia
16.
Int J Radiat Oncol Biol Phys ; 49(4): 1197-206, 2001 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-11240263

RESUMEN

PURPOSE: In current practice, planning for prostate brachytherapy is based on the state of the prostate at a particular instant in time. Because treatment occurs over an extended period, changes in the prostate volume (gland shrinkage) and seed displacement lead to disagreement between planned dosimetry to the prostate and the dose actually received by the prostate. Discrepancies between planned and actual dose to the rectum and urethra also occur. The purpose of this study is to investigate the possibility of defining an "effective planning volume" that compensates for changes in prostate volume and seed displacement. METHODS AND MATERIALS: Waterman's formula is used to estimate prostate shrinkage and seed displacement. The prostate volume and potential seed positions at days 0, 6, 12, 18, 24, and 30 are used in formulating time-dependent dosimetric treatment planning models. Both single-period and multi-period models are proposed and analyzed. A state-of-the-art computational engine generates unbiased, high-quality treatment plans in a matter of minutes. Plans are evaluated using coverage and conformity indices computed at specific times over a period of 30 days. The models allow dose to urethra and rectum to be strictly controlled at specific instants in time, or throughout the 30-day horizon. RESULTS: For plans generated from the single-period models-based on projected prostate volumes and potential seed positions on days t = 0, 6, 12, 18, 24, 30, respectively-as t increases, the conformity index improves while the coverage worsens. In particular, the best coverage and worst conformity are achieved for the plan generated using t = 0 (day 0) information. This plan provides over 99% coverage over the entire 30-day period, and while it has initial conformity index 1.24, the conformity index climbs to 1.58 by day 30. Conversely, the worst coverage and best conformity are achieved when the plan is generated using projected information from t = 30 (day 30). Plans based on projected data at day 30 yield an initial coverage of only 84%, with conformity scores less than 1.34 over the entire 30-day period. Among the multi-period plans, with the exception of the two-period plan obtained using day 0 and projected day 6 data, the average coverage is 98% while conformity indices below 1.46 are maintained throughout the 30-day horizon. Excessive dose to the urethra and rectum is observed when only day 0 dosimetric and volumetric data are imposed in the planning procedure. In this case, by day 30, 89% of urethra volume receives dose in excess of 120% of the remaining prescription dose. Similarly, 40% of rectum volume receives dose in excess of the prescribed upper dose bound of 78% of the remaining prescription dose. When multi-period dosimetric constraints for urethra and rectum are imposed, dose to these structures is controlled throughout the 30-day period. CONCLUSIONS: A planning method that takes into account prostate shrinkage and seed displacement over time can be used to adjust the balance between coverage and conformity. Incorporating projected future volumetric information is useful in providing more conformal plans, in some cases improving conformity by as much as 21% while sacrificing roughly 7% of initial coverage. Evidence of possible morbidity reduction to urethra and rectum via the use of multi-period dosimetric constraints on these structures is demonstrated. Among all plans considered, the plan obtained via the six-period model provides the best coverage and conformity over the 30-day horizon.


Asunto(s)
Braquiterapia/métodos , Neoplasias de la Próstata/radioterapia , Dosis de Radiación , Recto , Uretra , Humanos , Masculino , Neoplasias de la Próstata/patología , Factores de Tiempo
17.
Int J Radiat Biol ; 77(2): 205-13, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11236927

RESUMEN

PURPOSE: A long-standing problem is addressed: what form of the probability distribution for the number of clonogenic tumor cells remaining after fractionated radiotherapy should be used in the analysis aimed at evaluating the efficacy of cancer treatment? Over a period of years, a lack of theoretical results leading to a closed-form analytic expression for this distribution, even under very simplistic models of cell kinetics in the course of fractionated radiotherapy, was the most critical deterrent to the development of relevant methods of data analysis. MATERIALS AND METHODS: Rigorous mathematical results associated with a model of fractionated irradiation of tumors based on the iterated birth and death stochastic process are discussed. RESULTS: A formula is presented for the exact distribution of the number of clonogenic tumor cells at the end of treatment. It is shown that, under certain conditions, this distribution can be approximated by a Poisson distribution. An explicit formula for the parameter of the limiting Poisson distribution is given and sample computations aimed at evaluation of the convergence rate are reported. Another useful limit that retains a dose-response relationship in the distribution of the number of clonogens has been found. Practical implications of the key theoretical findings are discussed in the context of survival data analysis. CONCLUSIONS: This study answers some challenging theoretical questions that have been under discussion over a number of years. The results presented in this work provide mechanistic motivation for parametric regression models designed to analyze data on the efficacy of radiation therapy.


Asunto(s)
Neoplasias/radioterapia , Radioterapia/métodos , Humanos , Cinética , Modelos Biológicos , Modelos Teóricos , Distribución de Poisson , Células Tumorales Cultivadas
18.
Int J Radiat Oncol Biol Phys ; 49(4): 1033-43, 2001 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-11240245

RESUMEN

PURPOSE: This report presents the American Brachytherapy Society (ABS) guidelines for the use of brachytherapy for patients with soft tissue sarcoma. METHODS AND MATERIALS: Members of the ABS with expertise in soft tissue sarcoma formulated brachytherapy guidelines based upon their clinical experience and a review of the literature. The Board of Directors of the ABS approved the final report. RESULTS: Brachytherapy used alone or in combination with external beam irradiation is an established means of safely providing adjuvant local treatment after resection for soft tissue sarcomas in adults and in children. Brachytherapy options include low dose rate techniques with iridium 192 or iodine 125, fractionated high dose rate brachytherapy, or intraoperative high dose rate therapy. Recommendations are made for patient selection, techniques, dose rates, and dosages. Complications and possible interventions to minimize their occurrence and severity are reviewed. CONCLUSION: Brachytherapy represents an effective means of enhancing the therapeutic ratio, offering both biologic and dosimetric advantage in the treatment of patients with soft tissue sarcoma. The treatment approach used depends upon the institution, physician expertise, and the clinical situation. Guidelines are established for the use of brachytherapy in the treatment of soft tissue sarcomas in adults and in children. Practitioners and cooperative groups are encouraged to use these guidelines to formulate their treatment and dose-reporting policies. These guidelines will be modified, as further clinical results become available.


Asunto(s)
Braquiterapia/métodos , Sarcoma/radioterapia , Adulto , Factores de Edad , Braquiterapia/normas , Niño , Humanos , Recurrencia Local de Neoplasia/radioterapia , Selección de Paciente , Radiografía , Dosificación Radioterapéutica , Sarcoma/diagnóstico por imagen , Sarcoma/cirugía
19.
Trans Am Ophthalmol Soc ; 99: 187-95; discussion 195-7, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11797306

RESUMEN

PURPOSE: To compare the course and magnitude of change on the horizontal and vertical meridians of the cornea after 5 different incisions for cataract: extracapsular cataract extraction (ECCE), 6 mm superior scleral tunnel (6Sup), 3 mm superior scleral tunnel (3Sup), 3 mm temporal scleral tunnel (3Temp), and 3 mm temporal corneal incision (3Cor). METHODS: Retrospective chart review of 665 cases of preoperative regular astigmatism. The preoperative keratometry (K) reading was subtracted from the postoperative K reading to determine mean net change on each meridian at 1 day, 1 week, 2 weeks, 1 month, 1.5 months, 2 months, 4 months, 6 months and 12 months and at 6 month intervals thereafter. After the superior incisions, the temporal changes on each meridian are well described by an analytic model with an initial and final plateau. The changes after the temporal incisions are described by a linear equation. RESULTS: After each superior incision, the steepness and length of the transition from the initial to final plateau for each meridian depend on incision length. Considering the uncertainty of measuring K, the corneal meridians stabilized 4.5 months after ECCE, 1.2 months after 6Sup, and 0.3 months after 3Sup. No significant change was detected on the horizontal and vertical meridians after 3Temp and 3Cor. CONCLUSION: The magnitude and the duration of changes on the horizontal and vertical meridians of the cornea after cataract surgery depend on both incision length and location. Small temporal incisions induce less change than superior incisions.


Asunto(s)
Astigmatismo/etiología , Extracción de Catarata/efectos adversos , Córnea/patología , Técnicas de Sutura , Adulto , Anciano , Anciano de 80 o más Años , Astigmatismo/diagnóstico , Extracción de Catarata/métodos , Topografía de la Córnea , Femenino , Humanos , Masculino , Persona de Mediana Edad , Procedimientos Quirúrgicos Mínimamente Invasivos , Estudios Retrospectivos , Esclerótica/cirugía , Colgajos Quirúrgicos
20.
Nucl Instrum Methods Phys Res B ; 184(1-2): 135-57, 2001 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11863030

RESUMEN

A review of solid state microdosimetry is presented with an emphasis on silicon-based devices. The historical foundations and basics of microdosimetry are briefly provided. Various methods of experimental regional microdosimetry are discussed to facilitate a comparison with the more recent development of silicon microdosimetry. In particular, the performance characteristics of a proportional gas counter and a silicon microdosimeter are compared. Recent improvements in silicon microdosimetry address the issues of requirement specification, non-spherical shape, tissue equivalence, sensitive volume definition (charge collection complexity) and low noise requirements which have previously impeded the implementation of silicon-based microdosimetry. A prototype based on silicon-on-insulator technology is described along with some example results from clinical high LET radiotherapy facilities. A brief summary of the applications of microdosimetry is included.


Asunto(s)
Transferencia Lineal de Energía , Monitoreo de Radiación/instrumentación , Monitoreo de Radiación/métodos , Radioterapia/instrumentación , Silicio , Diseño de Equipo , Protección Radiológica , Radiometría , Radioterapia/métodos , Semiconductores , Nave Espacial/instrumentación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...